PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DR26F10034569907491!dupixent 300 MG 2 ML PEN 2ml — Amerisourcebergen Drug Corp

Amerisourcebergen Drug Corp holds $19.3B across 1,357,999 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DR25D1022. PoP ended Nov 4, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Amerisourcebergen Drug Corp
Recipient
Nov 4, 2025
PoP end
$239K
Obligated
$239K
Potential
424210
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amerisourcebergen Drug Corp — $90

Contract facts

Federal
Contract numberSPE2DR26F1003
Also listed asSPE2DR-26-F-1003
Also listed asSPE2DR25D1022-SPE2DR26F1003
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentAmerisourcebergen Drug Corp
CAGE1XUY5
UEIKABZK8W6PQT3
NAICS424210

No full NAICS 424210 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DR25D1022
Place of performanceCONSHOHOCKEN PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startNov 3, 2025
PoP end (current)Nov 4, 2025
Obligated$239K
Current value$239K
Potential value$239K

4569907491!DUPIXENT 300 MG/2 ML PEN 2ML is a federal award for Dla Troop Support held by Amerisourcebergen Drug Corp. Estimated value $239K ($239K obligated). Current period of performance ends Nov 4, 2025. Place of performance: CONSHOHOCKEN PA.

Recompete timing

Public
Past PoP end (290 days ago)

Current PoP ended Nov 4, 2025 (290 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Amerisourcebergen Drug Corp$19.3B obligated across 1,357,999 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($19.3B) · all agencies
Department of Defense (DOD)$19.3B · 100%Department of Health and Human Services (HHS)$7.6M · 0%Department of Veterans Affairs (VA)$5.9M · 0%Department of Justice (DOJ)$68K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C77026P0121
DROSPIRENONE
$321K
Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DR26F1003?

SPE2DR26F1003 (4569907491!dupixent 300 MG 2 ML PEN 2ml) is a Dla Troop Support award with a potential value of $239K, currently held by Amerisourcebergen Drug Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2DR-26-F-1003?

SPE2DR-26-F-1003 is the dashed form of PIID SPE2DR26F1003 (4569907491!dupixent 300 MG 2 ML PEN 2ml), held by Amerisourcebergen Drug Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2DR26F1003?

Dla Troop Support awarded SPE2DR26F1003 to Amerisourcebergen Drug Corp (potential $239K).

Who is the incumbent on SPE2DR26F1003?

Amerisourcebergen Drug Corp is the incumbent with $19.3B across 1357999 related awards in SCOUT’s public footprint. The current period of performance ends Nov 4, 2025.

When does Amerisourcebergen Drug Corp’s SPE2DR26F1003 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 4, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DR26F1003